{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T23:04:42Z","timestamp":1785539082961,"version":"3.56.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,9,27]],"date-time":"2024-09-27T00:00:00Z","timestamp":1727395200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,9,27]],"date-time":"2024-09-27T00:00:00Z","timestamp":1727395200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001711","name":"Schweizerischer Nationalfonds zur F\u00f6rderung der Wissenschaftlichen Forschung","doi-asserted-by":"publisher","award":["310030_185029"],"award-info":[{"award-number":["310030_185029"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001711","name":"Schweizerischer Nationalfonds zur F\u00f6rderung der Wissenschaftlichen Forschung","doi-asserted-by":"publisher","award":["310030_185029"],"award-info":[{"award-number":["310030_185029"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001711","name":"Schweizerischer Nationalfonds zur F\u00f6rderung der Wissenschaftlichen Forschung","doi-asserted-by":"publisher","award":["310030_185029"],"award-info":[{"award-number":["310030_185029"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-024-72826-w","type":"journal-article","created":{"date-parts":[[2024,9,27]],"date-time":"2024-09-27T15:02:14Z","timestamp":1727449334000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["CD8\u2009+\u2009T-cells restrict the development of peritoneal metastasis and support the efficacy of hyperthermic intraperitoneal chemotherapy (HIPEC)"],"prefix":"10.1038","volume":"14","author":[{"given":"Lilian","family":"Roth","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"Huynh-Russo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Heeb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sima","family":"Ulug\u00f6l","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael","family":"Freire Dos Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Breuer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Udo","family":"Ungeth\u00fcm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Haberecker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chantal","family":"Pauli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viktor","family":"Koelzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuno","family":"Lehmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anurag","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,9,27]]},"reference":[{"issue":"7","key":"72826_CR1","doi-asserted-by":"publisher","first-page":"e3000411","DOI":"10.1371\/journal.pbio.3000411","volume":"18","author":"N Percie du Sert","year":"2020","unstructured":"Percie du Sert, N. et al. Reporting animal research: explanation and elaboration for the ARRIVE guidelines 2.0. PLoS Biol.18(7), e3000411 (2020).","journal-title":"PLoS Biol."},{"issue":"3","key":"72826_CR2","doi-asserted-by":"publisher","first-page":"233","DOI":"10.3322\/caac.21772","volume":"73","author":"RL Siegel","year":"2023","unstructured":"Siegel, R. L., Wagle, N. S., Cercek, A., Smith, R. A. & Jemal, A. Colorectal cancer statistics, 2023. CA Cancer J. Clin.73 (3), 233\u2013254 (2023).","journal-title":"CA Cancer J. Clin."},{"issue":"12","key":"72826_CR3","doi-asserted-by":"publisher","first-page":"1709","DOI":"10.1016\/S1470-2045(16)30500-9","volume":"17","author":"J Franko","year":"2016","unstructured":"Franko, J. et al. Prognosis of patients with peritoneal metastatic colorectal cancer given systemic therapy: an analysis of individual patient data from prospective randomised trials from the Analysis and Research in cancers of the Digestive System (ARCAD) database. Lancet Oncol.17 (12), 1709\u20131719 (2016).","journal-title":"Lancet Oncol."},{"issue":"12","key":"72826_CR4","first-page":"1709","volume":"17","author":"E Breuer","year":"2021","unstructured":"Breuer, E. et al. Site of recurrence and survival after surgery for colorectal peritoneal metastasis. J. Natl. Cancer Inst. (2021).","journal-title":"J. Natl. Cancer Inst."},{"issue":"32","key":"72826_CR5","doi-asserted-by":"publisher","first-page":"52307","DOI":"10.18632\/oncotarget.10740","volume":"7","author":"M Riihimaki","year":"2016","unstructured":"Riihimaki, M., Hemminki, A., Sundquist, K., Sundquist, J. & Hemminki, K. Metastatic spread in patients with gastric cancer. Oncotarget. 7(32), 52307\u201352316 (2016).","journal-title":"Oncotarget"},{"issue":"1","key":"72826_CR6","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.ccell.2017.12.004","volume":"33","author":"R Yaeger","year":"2018","unstructured":"Yaeger, R. et al. Clinical sequencing defines the genomic landscape of metastatic colorectal cancer. Cancer Cell.33(1), 125-36e3 (2018).","journal-title":"Cancer Cell."},{"issue":"12","key":"72826_CR7","doi-asserted-by":"publisher","first-page":"e1242543","DOI":"10.1080\/2162402X.2016.1242543","volume":"5","author":"CT Seebauer","year":"2016","unstructured":"Seebauer, C. T. et al. Peritoneal carcinomatosis of colorectal cancer is characterized by structural and functional reorganization of the tumor microenvironment inducing senescence and proliferation arrest in cancer cells. Oncoimmunology. 5(12), e1242543 (2016).","journal-title":"Oncoimmunology"},{"issue":"5","key":"72826_CR8","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1097\/SLA.0000000000002899","volume":"268","author":"MA Schneider","year":"2018","unstructured":"Schneider, M. A. et al. Mutations of RAS\/RAF proto-oncogenes impair survival after cytoreductive surgery and HIPEC for peritoneal metastasis of colorectal origin. Ann. Surg.268(5), 845\u2013853 (2018).","journal-title":"Ann. Surg."},{"issue":"2","key":"72826_CR9","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/S1470-2045(20)30599-4","volume":"22","author":"F Quenet","year":"2021","unstructured":"Quenet, F. et al. Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy versus cytoreductive surgery alone for colorectal peritoneal metastases (PRODIGE 7): a multicentre, randomised, open-label, phase 3 trial. Lancet Oncol.22(2), 256\u2013266 (2021).","journal-title":"Lancet Oncol."},{"issue":"12","key":"72826_CR10","first-page":"1709","volume":"17","author":"A Arjona-S\u00e1nchez","year":"2023","unstructured":"Arjona-S\u00e1nchez, A. et al. Efficacy and safety of intraoperative hyperthermic intraperitoneal chemotherapy for locally advanced colon cancer: a phase 3 randomized clinical trial. JAMA Surg. (2023).","journal-title":"JAMA Surg."},{"issue":"5","key":"72826_CR11","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1200\/JCO.2008.19.7160","volume":"27","author":"D Elias","year":"2009","unstructured":"Elias, D. et al. Complete cytoreductive surgery plus intraperitoneal chemohyperthermia with oxaliplatin for peritoneal carcinomatosis of colorectal origin. J. Clin. Oncol.27(5), 681\u2013685 (2009).","journal-title":"J. Clin. Oncol."},{"issue":"16","key":"72826_CR12","doi-asserted-by":"publisher","first-page":"3756","DOI":"10.1002\/cncr.25116","volume":"116","author":"J Franko","year":"2010","unstructured":"Franko, J. et al. Cytoreductive surgery and hyperthermic intraperitoneal chemoperfusion versus systemic chemotherapy alone for colorectal peritoneal carcinomatosis. Cancer. 116(16), 3756\u20133762 (2010).","journal-title":"Cancer"},{"issue":"2","key":"72826_CR13","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1038\/nrclinonc.2009.217","volume":"7","author":"WP Ceelen","year":"2010","unstructured":"Ceelen, W. P. & Flessner, M. F. Intraperitoneal therapy for peritoneal tumors: biophysics and clinical evidence. Nat. Rev. Clin. Oncol.7(2), 108\u2013115 (2010).","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"4","key":"72826_CR14","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1002\/jso.21051","volume":"98","author":"S Kusamura","year":"2008","unstructured":"Kusamura, S., Dominique, E., Baratti, D., Younan, R. & Deraco, M. Drugs, carrier solutions and temperature in hyperthermic intraperitoneal chemotherapy. J. Surg. Oncol.98(4), 247\u2013252 (2008).","journal-title":"J. Surg. Oncol."},{"issue":"13","key":"72826_CR15","doi-asserted-by":"publisher","first-page":"9098","DOI":"10.1245\/s10434-021-10193-w","volume":"28","author":"A Bhatt","year":"2021","unstructured":"Bhatt, A. et al. HIPEC methodology and regimens: the need for an expert consensus. Ann. Surg. Oncol.28(13), 9098\u20139113 (2021).","journal-title":"Ann. Surg. Oncol."},{"issue":"1","key":"72826_CR16","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1097\/00000658-199501000-00004","volume":"221","author":"PH Sugarbaker","year":"1995","unstructured":"Sugarbaker, P. H. Peritonectomy procedures. Ann. Surg.221(1), 29\u201342 (1995).","journal-title":"Ann. Surg."},{"issue":"2","key":"72826_CR17","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.immuni.2015.11.024","volume":"44","author":"C Pfirschke","year":"2016","unstructured":"Pfirschke, C. et al. Immunogenic chemotherapy sensitizes tumors to checkpoint blockade therapy. Immunity. 44(2), 343\u2013354 (2016).","journal-title":"Immunity"},{"issue":"4","key":"72826_CR18","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1038\/onc.2009.356","volume":"29","author":"A Tesniere","year":"2010","unstructured":"Tesniere, A. et al. Immunogenic death of colon cancer cells treated with oxaliplatin. Oncogene. 29(4), 482\u2013491 (2010).","journal-title":"Oncogene"},{"key":"72826_CR19","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1146\/annurev-immunol-032712-100008","volume":"31","author":"G Kroemer","year":"2013","unstructured":"Kroemer, G., Galluzzi, L., Kepp, O. & Zitvogel, L. Immunogenic cell death in cancer therapy. Annu. Rev. Immunol.31, 51\u201372 (2013).","journal-title":"Annu. Rev. Immunol."},{"key":"72826_CR20","first-page":"88","volume":"2","author":"A Derrien","year":"2015","unstructured":"Derrien, A. et al. Therapeutic efficacy of Alpha-RIT using a (213)Bi-Anti-hCD138 antibody in a mouse model of ovarian peritoneal carcinomatosis. Front. Med. (Lausanne). 2, 88 (2015).","journal-title":"Front. Med. (Lausanne)"},{"issue":"6","key":"72826_CR21","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1111\/his.14438","volume":"79","author":"HJS Jones","year":"2021","unstructured":"Jones, H. J. S. et al. Stromal composition predicts recurrence of early rectal cancer after local excision. Histopathology. 79(6), 947\u2013956 (2021).","journal-title":"Histopathology"},{"issue":"11","key":"72826_CR22","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1038\/nm.3967","volume":"21","author":"J Guinney","year":"2015","unstructured":"Guinney, J. et al. The consensus molecular subtypes of colorectal cancer. Nat. Med.21(11), 1350\u20131356 (2015).","journal-title":"Nat. Med."},{"key":"72826_CR23","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.molimm.2017.12.005","volume":"113","author":"MLM Jongsma","year":"2019","unstructured":"Jongsma, M. L. M., Guarda, G. & Spaapen, R. M. The regulatory network behind MHC class I expression. Mol. Immunol.113, 16\u201321 (2019).","journal-title":"Mol. Immunol."},{"issue":"10","key":"72826_CR24","doi-asserted-by":"publisher","first-page":"4940","DOI":"10.4049\/jimmunol.1103136","volume":"188","author":"A Neerincx","year":"2012","unstructured":"Neerincx, A., Rodriguez, G. M., Steimle, V. & Kufer, T. A. NLRC5 controls basal MHC class I gene expression in an MHC enhanceosome-dependent manner. J. Immunol.188(10), 4940\u20134950 (2012).","journal-title":"J. Immunol."},{"issue":"10","key":"72826_CR25","doi-asserted-by":"publisher","first-page":"2551","DOI":"10.1038\/bjc.2014.161","volume":"110","author":"A Ling","year":"2014","unstructured":"Ling, A., Edin, S., Wikberg, M. L., Oberg, A. & Palmqvist, R. The intratumoural subsite and relation of CD8(+) and FOXP3(+) T lymphocytes in colorectal cancer provide important prognostic clues. Br. J. Cancer. 110(10), 2551\u20132559 (2014).","journal-title":"Br. J. Cancer"},{"issue":"8","key":"72826_CR26","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1056\/NEJMoa1003466","volume":"363","author":"FS Hodi","year":"2010","unstructured":"Hodi, F. S. et al. Improved survival with ipilimumab in patients with metastatic melanoma. N Engl. J. Med.363(8), 711\u2013723 (2010).","journal-title":"N Engl. J. Med."},{"key":"72826_CR27","doi-asserted-by":"crossref","unstructured":"Peng, J. et al. Immune Cell Infiltration in the Microenvironment of Liver Oligometastasis from Colorectal Cancer: Intratumoural CD8\/CD3 Ratio Is a Valuable Prognostic Index for Patients Undergoing Liver Metastasectomy. Cancers (Basel). 11(12). (2019).","DOI":"10.3390\/cancers11121922"},{"issue":"4","key":"72826_CR28","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1016\/j.celrep.2016.10.009","volume":"17","author":"M Giannakis","year":"2016","unstructured":"Giannakis, M. et al. Genomic correlates of Immune-Cell infiltrates in Colorectal Carcinoma. Cell. Rep.17(4), 1206 (2016).","journal-title":"Cell. Rep."},{"issue":"8","key":"72826_CR29","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1002\/jso.25899","volume":"121","author":"MK Stein","year":"2020","unstructured":"Stein, M. K. et al. Comprehensive tumor profiling reveals unique molecular differences between peritoneal metastases and primary colorectal adenocarcinoma. J. Surg. Oncol.121(8), 1320\u20131328 (2020).","journal-title":"J. Surg. Oncol."},{"issue":"5","key":"72826_CR30","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1038\/s41416-021-01620-6","volume":"126","author":"SG Larsen","year":"2022","unstructured":"Larsen, S. G. et al. Impact of KRAS, BRAF and microsatellite instability status after cytoreductive surgery and HIPEC in a national cohort of colorectal peritoneal metastasis patients. Br. J. Cancer. 126(5), 726\u2013735 (2022).","journal-title":"Br. J. Cancer"},{"key":"72826_CR31","doi-asserted-by":"crossref","unstructured":"Lehmann, K. et al. New insight into hyperthermic intraperitoneal chemotherapy: induction of oxidative stress dramatically enhanced tumor killing in in vitro and in vivo models. Ann Surg.256(5), 730\u2013737; discussion 7\u20138. (2012).","DOI":"10.1097\/SLA.0b013e3182737517"},{"issue":"9","key":"72826_CR32","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1038\/sj.bjc.6602201","volume":"91","author":"T Chiba","year":"2004","unstructured":"Chiba, T. et al. Intraepithelial CD8\u2009+\u2009T-cell-count becomes a prognostic factor after a longer follow-up period in human colorectal carcinoma: possible association with suppression of micrometastasis. Br. J. Cancer. 91(9), 1711\u20131717 (2004).","journal-title":"Br. J. Cancer"},{"key":"72826_CR33","doi-asserted-by":"publisher","first-page":"103547","DOI":"10.1016\/j.ebiom.2021.103547","volume":"71","author":"D Jiang","year":"2021","unstructured":"Jiang, D. et al. Automated assessment of CD8(+) T-lymphocytes and stroma fractions complement conventional staging of colorectal cancer. EBioMedicine. 71, 103547 (2021).","journal-title":"EBioMedicine"},{"issue":"5","key":"72826_CR34","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1093\/annonc\/mds614","volume":"24","author":"MA Merok","year":"2013","unstructured":"Merok, M. A. et al. Microsatellite instability has a positive prognostic impact on stage II colorectal cancer after complete resection: results from a large, consecutive Norwegian series. Ann. Oncol.24(5), 1274\u20131282 (2013).","journal-title":"Ann. Oncol."},{"issue":"3","key":"72826_CR35","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1200\/JCO.2005.01.086","volume":"23","author":"S Popat","year":"2005","unstructured":"Popat, S., Hubner, R. & Houlston, R. S. Systematic review of microsatellite instability and colorectal cancer prognosis. J. Clin. Oncol.23(3), 609\u2013618 (2005).","journal-title":"J. Clin. Oncol."},{"issue":"1","key":"72826_CR36","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1038\/s41467-021-21045-2","volume":"12","author":"P Tallon de Lara","year":"2021","unstructured":"Tallon de Lara, P. et al. CD39(+)PD-1(+)CD8(+) T cells mediate metastatic dormancy in breast cancer. Nat. Commun.12(1), 769 (2021).","journal-title":"Nat. Commun."},{"issue":"3","key":"72826_CR37","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1038\/s41590-019-0312-6","volume":"20","author":"BC Miller","year":"2019","unstructured":"Miller, B. C. et al. Subsets of exhausted CD8(+) T cells differentially mediate tumor control and respond to checkpoint blockade. Nat. Immunol.20(3), 326\u2013336 (2019).","journal-title":"Nat. Immunol."},{"issue":"2","key":"72826_CR38","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1038\/onc.2015.82","volume":"35","author":"B Zunino","year":"2016","unstructured":"Zunino, B. et al. Hyperthermic intraperitoneal chemotherapy leads to an anticancer immune response via exposure of cell surface heat shock protein 90. Oncogene. 35(2), 261\u2013268 (2016).","journal-title":"Oncogene"},{"issue":"2","key":"72826_CR39","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1097\/SLA.0b013e3182263933","volume":"254","author":"F Quenet","year":"2011","unstructured":"Quenet, F. et al. Results of two bi-institutional prospective studies using intraperitoneal oxaliplatin with or without irinotecan during HIPEC after cytoreductive surgery for colorectal carcinomatosis. Ann. Surg.254(2), 294\u2013301 (2011).","journal-title":"Ann. Surg."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-72826-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-72826-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-72826-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,27]],"date-time":"2024-09-27T15:14:28Z","timestamp":1727450068000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-72826-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,27]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["72826"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-72826-w","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,27]]},"assertion":[{"value":"24 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 September 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The informed consent was obtained from all participants included in this study. The research has been performed in accordance with the Declaration of Helsinki.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declaration including human subjects"}},{"value":"All experiments were performed in accordance with relevant guidelines and regulations. And the study is reported in accordance with the ARRIVE guidelines<sup>1<\/sup>.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declaration including experimental animals"}}],"article-number":"22324"}}